116 related articles for article (PubMed ID: 1933851)
21. Effect of modulators on 5-fluorouracil metabolite patterns in murine colon carcinoma determined by in vitro 19F nuclear magnetic resonance spectroscopy.
Kamm VJ; Rietjens IM; Vervoort J; Heerschap A; Rosenbusch G; Hofs HP; Wagener DJ
Cancer Res; 1994 Aug; 54(16):4321-6. PubMed ID: 8044779
[TBL] [Abstract][Full Text] [Related]
22. Local disposition kinetics of floxuridine after intratumoral and subcutaneous injection as monitored by [19F]-nuclear magnetic resonance spectroscopy in vivo.
Port R; Hanisch F; Becker M; Bachert P; Zeller J
Cancer Chemother Pharmacol; 1999; 44(1):65-73. PubMed ID: 10367751
[TBL] [Abstract][Full Text] [Related]
23. Fluorine-19 or phosphorus-31 NMR spectroscopy: a suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs.
Martino R; Gilard V; Desmoulin F; Malet-Martino M
J Pharm Biomed Anal; 2005 Aug; 38(5):871-91. PubMed ID: 16087049
[TBL] [Abstract][Full Text] [Related]
24. Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver.
Klomp D; van Laarhoven H; Scheenen T; Kamm Y; Heerschap A
NMR Biomed; 2007 Aug; 20(5):485-92. PubMed ID: 17131325
[TBL] [Abstract][Full Text] [Related]
25. An 19F magnetic resonance-based in vivo assay of solid tumor methotrexate resistance: proof of principle.
Spees WM; Gade TP; Yang G; Tong WP; Bornmann WG; Gorlick R; Koutcher JA
Clin Cancer Res; 2005 Feb; 11(4):1454-61. PubMed ID: 15746046
[TBL] [Abstract][Full Text] [Related]
26. Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy.
Schlemmer HP; Becker M; Bachert P; Dietz A; Rudat V; Vanselow B; Wollensack P; Zuna I; Knopp MV; Weidauer H; Wannenmacher M; van Kaick G
Cancer Res; 1999 May; 59(10):2363-9. PubMed ID: 10344745
[TBL] [Abstract][Full Text] [Related]
27. Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits.
Wolf W; Presant CA; Servis KL; el-Tahtawy A; Albright MJ; Barker PB; Ring R; Atkinson D; Ong R; King M
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):492-6. PubMed ID: 2296605
[TBL] [Abstract][Full Text] [Related]
28. Monitoring fluoropyrimidine metabolism in solid tumors with in vivo (19)F magnetic resonance spectroscopy.
van Laarhoven HW; Punt CJ; Kamm YJ; Heerschap A
Crit Rev Oncol Hematol; 2005 Dec; 56(3):321-43. PubMed ID: 15982898
[TBL] [Abstract][Full Text] [Related]
29. [Studies in vivo and in vitro on the influence of 5-fluorouracil and n'-(2'-furanidyl)-5-fluorouracil on the walker carcinosarcoma 256 in the rat (author's transl)].
Mattern J; Volm M; Wayss K; Weber N
Arzneimittelforschung; 1980; 30(6):981-4. PubMed ID: 6774738
[TBL] [Abstract][Full Text] [Related]
30. Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo.
McSheehy PM; Prior MJ; Griffiths JR
Br J Cancer; 1989 Sep; 60(3):303-9. PubMed ID: 2789936
[TBL] [Abstract][Full Text] [Related]
31. In vivo 19F nuclear magnetic resonance spectroscopy: a potential monitor of 5-fluorouracil pharmacokinetics and metabolism.
Evelhoch JL
Invest New Drugs; 1989 Apr; 7(1):5-12. PubMed ID: 2661482
[TBL] [Abstract][Full Text] [Related]
32. In vivo monitoring of changes in 5-fluorouracil metabolism induced by methotrexate measured by 19F NMR spectroscopy.
Koutcher JA; Sawyer RC; Kornblith AB; Stolfi RL; Martin DS; Devitt ML; Cowburn D; Young CW
Magn Reson Med; 1991 May; 19(1):113-23. PubMed ID: 2046526
[TBL] [Abstract][Full Text] [Related]
33. Fluorine nuclear magnetic resonance, a privileged tool for metabolic studies of fluoropyrimidine drugs.
Martino R; Malet-Martino M; Gilard V
Curr Drug Metab; 2000 Nov; 1(3):271-303. PubMed ID: 11465049
[TBL] [Abstract][Full Text] [Related]
34. Development of an in vivo 19F magnetic resonance method for measuring oxygen deficiency in tumors.
Raleigh JA; Franko AJ; Kelly DA; Trimble LA; Allen PS
Magn Reson Med; 1991 Dec; 22(2):451-66. PubMed ID: 1812379
[TBL] [Abstract][Full Text] [Related]
35. Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver.
Klomp DW; Van Laarhoven HW; Kentgens AP; Heerschap A
Magn Reson Med; 2003 Aug; 50(2):303-8. PubMed ID: 12876706
[TBL] [Abstract][Full Text] [Related]
36. 19F-MRS studies of fluorinated drugs in humans.
Wolf W; Presant CA; Waluch V
Adv Drug Deliv Rev; 2000 Mar; 41(1):55-74. PubMed ID: 10699305
[TBL] [Abstract][Full Text] [Related]
37. In vivo 5-fluorouracil and fluoronucleotide T1 relaxation time measurements using the variable nutation angle method.
Gade TP; Spees WM; Le HC; Zakian KL; Ponomarev V; Doubrovin M; Gelovani JG; Koutcher JA
Magn Reson Med; 2004 Jul; 52(1):169-73. PubMed ID: 15236381
[TBL] [Abstract][Full Text] [Related]
38. 5-Fluorouracil metabolite patterns in viable and necrotic tumor areas of murine colon carcinoma determined by 19F NMR spectroscopy.
Kamm YJ; Heerschap A; Rosenbusch G; Rietjens IM; Vervoort J; Wagener DJ
Magn Reson Med; 1996 Sep; 36(3):445-50. PubMed ID: 8875416
[TBL] [Abstract][Full Text] [Related]
39. Interest of fluorine-19 nuclear magnetic resonance spectroscopy in the detection, identification and quantification of metabolites of anticancer and antifungal fluoropyrimidine drugs in human biofluids.
Martino R; Gilard V; Desmoulin F; Malet-Martino M
Chemotherapy; 2006; 52(5):215-9. PubMed ID: 16864998
[TBL] [Abstract][Full Text] [Related]
40. Assignment and pH dependence of the 19F-NMR resonances from the fluorouracil anabolites involved in fluoropyrimidine chemotherapy.
Lutz NW; Hull WE
NMR Biomed; 1999 Jun; 12(4):237-48. PubMed ID: 10421915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
